In 2013, Daiichi had launched the arbitration proceedings in Singapore.
Domestic jet fuel prices are up 7%, but are still 14% lower on a y-o-y basis. While lower fuel prices have brought respite to airlines, their non-fuel costs are rising because of rupee depreciation
Alkem Labs was issued drug alerts twice last year -- in June and July -- for its drug Glimekem.
The draft bill allows euthanasia for patients who can take informed decisions; doctors to be protected from liability.
Daiichi alleged that Singh brothers had concealed and misrepresented critical information concerning US Food and Drug Administration and Department of Justice investigations into Ranbaxy
The working groups will comprise representatives of airlines, airport operators and the AAI.
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
Jet's advertising and that of most other airlines has been limited to new routes or promotional fares.
Etihad is the fourth airline to operate the super jumbo aircraft to India.
Company aims to build five Rs 100 cr-plus brands and launch products from South African arm in domestic market
While the Taj remains popular amongst celebrity guests, many ordinary foreign visitors are skipping it
NHAI to pull plug on Rs 3,000-crore ventures for poor show
Officials also denied that security concern regarding construction of multi-level parking lot near the ATC tower was behind the idea to build control tower in Kalina
Lohani orders staff to ensure maintenance and cleanliness of hi-lift catering trucks
At the heart of the current controversy is the government's FDI rule
Most airlines have fattened their profits, turned the corner, or cut their losses, except AirAsia India.
Sanjeev Vashishta, chief executive officer at SRL Diagnostics, talks to Deepak Patel about expansion plans and regulations for the sector.
Govt bans brands with annual sales worth Rs 3,728 crore.
The government is keeping its options open.
AirAsia India began operations in June 2014.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances